Activating healthcare AI in the USA is building momentum—from expanding lung cancer surveillance to prioritizing patient cases and expediting emergency stroke care.
AI-powered
Radiology for
Proven Results
Reaping the clinical, operational, and financial benefits of AI requires carefully selecting a partner with proven results.
Qure.ai has 18 FDA clearances, 60+ published evidence papers, and an AI deployment footprint in more than 90 countries.
Meet with us at the Radiological Society of North America (RSNA) 2024 Annual Meeting for discussion, debate, and demonstrations.
Speaking at RSNA :
Hear from the Global AI Activation Ambassadors
Speaker Session • Dec 02, 2024 Monday
Incidental lung cancer detection on chest X-rays
Time: Monday | 11.00 AM CST
Speaker Session • Dec 03, 2024 Tuesday
Chest Xray AI: Patients, Partners and Pathways Summarising the work of LungIMPACT, this session will cover insights into patient views of AI in lung cancer, staff engagement and opportunities to optimise pathways with AI as a catalyst.
Time: Tuesday | 11:30 AM CST
Speaker Session • Dec 04, 2024 Wednesday
The power of Chest X-ray AI and early lung cancer detection: Prelim results of RADICAL study
Time: Wednesday | 11:30 AM CST
Hear from the Global AI Activation Ambassadors
Speaker Session • Dec 02, 2024 Monday
Incidental lung cancer detection on chest X-rays
Time: Monday | 11.00 AM CST
Speaker Session • Dec 03, 2024 Tuesday
Chest Xray AI: Patients, Partners and Pathways Summarising the work of LungIMPACT, this session will cover insights into patient views of AI in lung cancer, staff engagement and opportunities to optimise pathways with AI as a catalyst.
Time: Tuesday | 11:30 AM CST
Speaker Session • Dec 04, 2024 Wednesday
The power of Chest X-ray AI and early lung cancer detection: Prelim results of RADICAL study
Time: Wednesday | 11:30 AM CST
Transforming Patient Pathways
Lung Cancer Suite | Care Coordination | ER Suite
The integration of AI is redefining patient care, especially in critical areas like emergency medicine and oncology. These innovative digital health solutions enhance diagnostic accuracy and improve care coordination, ultimately leading to better patient outcomes.
Lung Cancer Suite – Identify | Measure | Track
- qXR is the world’s most widely used AI for comprehensive Chest X-ray reporting, providing pre-read assistance in <1 minute with detailed lung findings. It has been proven to detect one lung cancer case for every 1,120 chest X-rays, underscoring the solution’s efficiency and effectiveness in real-world settings.
- qCT helps in early detection and monitoring of lung nodules. It gives precise quantification, comprehensive characterization, and 3D visualization to ensure no missed opportunities for early intervention. Studies have shown that it delivers 35% more lung cancer referrals on CT scans, validating how the AI enables actionable outcomes.
- qTrack is a comprehensive lung nodule management platform that enables care coordination. Results show that it facilitates follow-ups for 78% of patients with incidental pulmonary nodules (IPNs), which is essential for continuity of care and treatment planning.
ER Suite - Rapid Detection and Triage
- qER is an AI-enabled head CT solution widely deployed globally to expedite the detection, triage, and quantification of traumatic brain injuries and strokes. Studies have shown it can flag critical cases in approximately 100 seconds, helping clinicians identify suspected stroke cases or neuro-critical injuries much earlier, assisting in diagnostic decision-making and streamlining the flow of patients into treatment pathways or onward discharge.
- qMSK is an AI solution for fracture detection, which helps localize signs of fractures in adult patients. Studies have shown it has a sensitivity of 91%.
*Please check with our U.S team to find out about our FDA-cleared portfolio
Read More News
